MARKET

ARWR

ARWR

Arrowhead Pharma
NASDAQ
88.11
-1.13
-1.27%
Opening 14:57 08/12 EDT
OPEN
89.09
PREV CLOSE
89.24
HIGH
90.61
LOW
88.11
VOLUME
486.27K
TURNOVER
--
52 WEEK HIGH
95.49
52 WEEK LOW
15.81
MARKET CAP
12.45B
P/E (TTM)
-39.3296
1D
5D
1M
3M
1Y
5Y
1D
Why Arrowhead Pharmaceuticals (ARWR) Is Back In The Spotlight
Simply Wall St · 2h ago
How Investors Are Reacting To Arrowhead Pharmaceuticals (ARWR) Soaring Sales But Deepening Losses
Simply Wall St · 1d ago
Weekly Report: what happened at ARWR last week (0803-0807)?
Weekly Report · 2d ago
Arrowhead Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 6d ago
Arrowhead Pharmaceuticals Price Target Raised to $120.00/Share From $115.00 by HC Wainwright & Co.
Dow Jones · 6d ago
HC Wainwright & Co. Maintains Buy on Arrowhead Pharma, Raises Price Target to $120
Benzinga · 6d ago
Arrowhead price target raised to $120 from $115 at H.C. Wainwright
TipRanks · 6d ago
Arrowhead Pharmaceuticals (ARWR) Stock Retreats As Losses Deepen Behind Phase III Progress
Simply Wall St · 6d ago
More
About ARWR
Arrowhead Pharmaceuticals, Inc. develops medicines that treat intractable diseases by silencing the genes that cause them. The Company's therapies, using a broad portfolio of ribonucleic acid (RNA) chemistries and modes of delivery, trigger the RNA interference (RNAi) mechanism to induce rapid, deep and durable knockdown of target genes. Its Targeted RNAi Molecule (TRiMTM) platform utilizes ligand-mediated delivery and is designed to enable tissue-specific targeting while being structurally simple. It is focused on various therapeutic areas, such as cardiometabolic, pulmonary, liver, neuromuscular and others. It has over 18 discovered drug candidates in clinical trials ranging from early stage (Phase I) to late stage (Phase III). The Company's pipeline products include plozasiran, zodasiran, olpasiran, ARO-RAGE, SRP-1002, GSK4532990, fazirsiran, daplusiran/tomligisiran, ARO-CFB, ARO-INHBE, ARO-C3, ARO-PNPLA3, SRP-1001 (ARO-DUX4), SRP-1003 (ARO-DM1), SRP-1004 (ARO-ATXN2), and others.

Webull offers Arrowhead Pharmaceuticals Inc stock information, including NASDAQ: ARWR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ARWR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ARWR stock methods without spending real money on the virtual paper trading platform.